Cargando...
Variation in nomenclature of somatic variants for selection of oncological therapies: Can we reach a consensus soon?
A standardized nomenclature for reporting oncology biomarker variants is key to avoid misinterpretation of results and unambiguous registration in clinical databases. External quality assessment (EQA) schemes have revealed a need for more consistent nomenclature use in clinical genetics. We evaluate...
Guardado en:
| Publicado en: | Hum Mutat |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6973115/ https://ncbi.nlm.nih.gov/pubmed/31553104 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/humu.23926 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|